Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.

SILVERNAIL LAUREN P

Graves Adrienne L

BOLL ANDREW R.

BAUM MARK L

Opaleye Management Inc.

Teaching traders how to trade with conviction.

Flow Education @ BullFlow https://t.co/iWqwhYLiqb
Live Trading @ Stock Talk Insiders https://t.co/8mopfzD9l9

Danny Naz

CEO/CIO at @LuptonCapital and @FirstWaveFund, long-biased hedge fund, focused on undervalued growth companies with catalysts that can triple within 2-4 years

Jonah Lupton

Product Manager.
AI infrastructure research | Data centers, memory, networking.
Tracking the supply chain.

On Substack ⬇️ Try it free for 7 days

TheBigBerbowski

Daily market commentary. Investing is hard. That’s why it can be rewarding. TheStreetPro • SharkInvesting • Michigan Law & Business. Developing PegMarkets. NIA.

Harrow Health Inc (HROW) Stock Price, Analysis & Trade Signals